| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC2150 |
| Trial ID | NCT04030195 |
| Disease | Chronic Lymphocytic Leukemia | Non-Hodgkin's Lymphoma | Small Lymphocytic Lymphoma | Human Monocytic Ehrlichiosis |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PBCAR20A |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL |
| Year | 2020 |
| Country | United States |
| Company sponsor | Precision BioSciences, Inc. |
| Other ID(s) | PBCAR20A-01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||